Lupus Clinical Trials in New York

Showing 201-220 of 239 trials

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

NCT02391259

This is a multicenter, randomized, double-blind, placebo-controlled, sequential rising single-dose study in which approximately 56 subjects with SLE will be enrolled in 7 dosing cohorts

Systemic Lupus Erythematosus

Amgen57 participantsStarted Nov 2006

Anniston, Alabama, United States • Phoenix, Arizona, United States • Los Angeles, California, United States +10 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder

NCT01163032

The purpose of this study is to evaluate the efficacy and safety of a six month double-mask treatment of tasimelteon or placebo in male and female subjects with Non-24-Hour Sleep-Wake Disorder

Non-24-Hour Sleep-Wake Disorder

Vanda Pharmaceuticals136 participantsStarted Aug 2010

Phoenix, Arizona, United States • Orange, California, United States • Palo Alto, California, United States +25 more locations

A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder

Lupus Trials in Other Cities

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus

World Trade Center (WTC) CHEST

Study of Epratuzumab in Systemic Lupus Erythematosus

PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome

Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients

Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL

Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)

An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE)

PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus

Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder

The Role of ITGAM in Systemic Lupus Erythematosus

Etanercept for the Treatment of Lupus Nephritis

A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

Heart Biomarker Evaluation in Apnea Treatment

Feasibility Study to Determine the Effects of Phrenic Nerve Stimulation in Patients With Periodic Breathing

Other Conditions in New York